Agios Pharmaceuticals
AGIO
AGIO
201 hedge funds and large institutions have $4.06B invested in Agios Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 80 increasing their positions, 50 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
19% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 32
3.17% more ownership
Funds ownership: 99.8% → 102.97% (+3.2%)
3% more funds holding
Funds holding: 196 → 201 (+5)
Holders
201
Holding in Top 10
4
Calls
$55M
Puts
$26.8M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$28.6M | |
| 3 | +$23.1M | |
| 4 |
Goldman Sachs
New York
|
+$21.6M |
| 5 |
Alkeon Capital Management
New York
|
+$16M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$10.6M | |
| 3 | -$9.96M | |
| 4 |
D.E. Shaw & Co
New York
|
-$7.47M |
| 5 |
CC
Casdin Capital
New York
|
-$7.42M |